News

Superabsorbent Failure: The Product That Caused Toxic Shock Syndrome

Medical Testing Recall (illustrative image)
Photo: U.S. Navy photo by Photographer's Mate 3rd Class Kristopher Wilson / Wikimedia Commons (Public domain)

The moment a user experienced the product, the sensation was revolutionary, yet deeply alarming. The material, designed to be superabsorbent, was meant to revolutionize menstrual hygiene, promising unparalleled capacity. It was a product that worked by expanding into a cup shape within the body, absorbing fluid at a rate that defied previous norms. Furthermore, the sheer magnitude of its absorption capacity—nearly twenty times its own weight in fluid—was a feat of modern chemical engineering.

This device, marketed under the name Rely, represented a significant leap in feminine care technology. Developed and launched by Procter & Gamble in 1975, it was engineered to compete vigorously in an established market. The product utilized specialized materials, specifically crosslinked carboxymethylcellulose and polyester foam, to achieve its advertised performance. The company promoted the convenience and advanced nature of the product, even using the catchy slogan: “It even absorbs the worry!”

Read more: Award-Winning Lies: The Journalist Who Fabricated His Career

The early push into the market

The groundwork for the product was laid years before its official launch, beginning with test-marketing efforts. Procter & Gamble initially tested the device in locations including Rochester and Fort Wayne during 1974. Crucially, this testing phase took place under a grandfather clause, predating major changes to FDA regulations that occurred before 1976. Following these preliminary trials, samples began being systematically mailed out to women across the United States starting in 1975.

The distribution effort was vast, with estimates suggesting that research personnel alone distributed approximately 45 million sample packs. The promotional efforts were highly visible, often featuring commercials that concluded with the memorable line: “Remember, They named it Rely.” One user, whose experience was reportedly shared with researcher Sharra Vostral, commented: “wondered whether I had lost my virginity, that thing had gotten so huge.”

The alarming chemical reaction

Despite its advertised capabilities, the superabsorbent nature of the material created unforeseen biological complications. The intense absorption of fluid resulted in vaginal dryness, a condition that proved problematic for users. More critically, the chemistry of the environment that the product created altered the natural vaginal fluid viscosity. This change in fluid composition subsequently fostered an environment highly conducive to the uncontrolled growth of bacteria.

These adverse effects eventually culminated in serious health concerns, linking the product to a condition known as Toxic Shock Syndrome (TSS). This growing medical link prompted official action, leading the Centers for Disease Control (CDC) to issue a report directly connecting the use of Rely to the onset of TSS. These documented health issues necessitated a major corporate response.

The withdrawal and reckoning

Faced with mounting evidence and public health worry, Procter & Gamble initiated a recall of the product on September 22, 1980. The company subsequently entered into a formal consent agreement with the FDA regarding the retrieval of the product from the market. The financial implications of the recall were immense, leading the company to set aside a substantial sum of $150 million (pre-tax) merely to cover the costs associated with the market removal.

The legal repercussions followed quickly, culminating in a March 1982 jury verdict that found Procter & Gamble negligent for the sale of a defective product. The legal challenge reached its apex in April 1982, when a jury found the company liable for a death that stemmed from TSS. By August 1982, the company had settled a specific suit with an eighteen-year-old woman, bringing closure to a deeply troubled chapter.

A lasting lesson in industrial design

The saga of Rely remains a stark example of how advanced technology can intersect disastrously with biology. It serves as a powerful case study in product liability, highlighting the critical need for manufacturers to anticipate unintended biological consequences. The vast distribution of samples and the resulting health crises underscore that even seemingly benign consumer goods can carry profound, systemic risks.

The sheer scale of the recall and the subsequent legal battles established precedents for corporate accountability in medical device manufacturing. The story of Rely serves as a permanent warning: even the most ingenious solutions must be scrutinized for their hidden costs. Remember, they named it Rely.

More from Ungrid Now

Background: Wikipedia

The Daily Ungrid

Five stories you can’t ignore, every morning at 7.

Join 412,000 readers. Free, and one tap to leave.

More from Ungrid Now